Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Effect of Naltrexone and Bupropion Combination on Weight Loss and Smoking Cessation in Obese, Cigarette-smoking Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Pilot Trial of Naltrexone-Bupropion Combination Versus Placebo Combined With Bupropion for Weight Loss in Comorbid Schizophrenia
This study ended early.
In New HavenNetwork Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)
Read the official source — NCT01394757Brain Network Dysfunction as a Model for Schizophrenia: Connectivity Alterations Using Ketamine and Pharmacological Magnetic Resonance Imaging
This study has finished and is no longer accepting participants.
In Vienna
Neural Biomarkers of Electroconvulsive Therapy Response in Schizophrenia
Current recruitment status is unconfirmed.
In Glen OaksNeurobiological Effects of Oxytocin on Metacognitive Deficits in Schizophrenia: A Pharmacological - Imaging Genetics Study
This study has finished and is no longer accepting participants.
In BangaloreNeurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
Read the official source — NCT01720316Pilot Study of Glycine Augmentation in Carriers of a Mutation in the Gene Encoding Glycine Decarboxylase
This study has finished and is no longer accepting participants.
In BelmontA Neurophysiological Investigation of the Effectiveness of Web-based Exergaming Platform of Cognitive and Physical Training in Schizophrenic Patients
This study has finished and is no longer accepting participants.
In Thessaloniki
This study was withdrawn before enrollment.
In BronNicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
Read the official source — NCT01213524Biological and Behavioral Mechanisms of Smoking in Schizophrenia
This study has finished and is no longer accepting participants.
In ProvidenceNicotinic Modulation of (NMDA) Receptor Antagonist Schizophrenia-like Information Processing Deficits in Humans
This study has finished and is no longer accepting participants.
In West HavenPaliperidone Palmitate in Early Schizophrenia - A Retrospective, Non-interventional Study of Patients With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate Over a 12-Month Period
This study has finished and is no longer accepting participants.
Multiple locations, including RijekaNon-Invasive Brain Stimulation for Clinical Intervention for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients
This study was withdrawn before enrollment.
In MinneapolisWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.